, Tracking Stock Market Picks
Enter Symbol:
Lhc Group (LHCG) [hlAlert]

Mkt Outperform
up 156.94 %

Lhc Group (LHCG) upgraded to Mkt Outperform with price target $21 by Avondale Partners

Posted on: Friday,  Feb 29, 2008  2:25 PM ET by Avondale Partners

Avondale Partners rated Mkt Outperform Lhc Group (NASDAQ: LHCG) on 02/29/2008, when the stock price was $17.00.
Since then, Lhc Group has gained 156.94% as of 09/01/2015's recent price of $43.68.
If you would have followed this Avondale Partners's recommendation on LHCG, you would have gained 156.94% of your investment in 2741 days.

LHC Group provides post-acute healthcare services primarily to Medicare beneficiaries in rural markets in the southern United States. They provide home-based services through their home nursing agencies and hospices and facility-based services through their long-term acute care hospitals and outpatient rehabilitation clinics.

Avondale’s research analysts are charged with producing high quality, independent, value-added, and timely investment analysis / advice. The firm’s strategy is to deemphasize maintenance research, and instead direct the overwhelming majority of our efforts on developing well-constructed, actionable recommendations, in part by leveraging proprietary networks of industry contacts. Avondale’s growing research department now totals 25 professionals. Senior analysts average 14 years of industry experience and are routinely recognized by a variety of nationally known rating entities. In the last two years, Avondale Analysts were named to the Wall Street Journal’s Best on the Street poll as well as’s Top Analyst Rankings.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/29/2008 2:25 PM Buy
17.00 21.00
as of 12/24/2008
1 Week up  9.47 %
1 Month up  14.40 %
3 Months down  -27.78 %
1 YTD down  -35.80 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/7/2007 3:25 PM Hold
25.00 27.00
11/2/2007 1:25 PM Buy
23.40 27.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy